Cellular basis of diabetic nephropathy: IV Antioxidant enzyme mRNA expression levels in skin fibroblasts of type 1 diabetic sibling pairs

Nephrology Dialysis Transplantation

Volumn 21, Issue 11, 2006, Pages 3122-3126

  Caramori, Maria Luiza ^a   Kim, Youngki ^a   Fioretto, Paola ^b   Huang, Chunmei ^a   Rich, Stephen S ^c   Miller, Michael E ^c   Russell, Gregory B ^c   Mauer, Michael ^a,d  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF PADOVA   (Italy)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d NONE   (United States)

Author keywords

Genetics of diabetic nephropathy; Glomerular structure; Type 1 diabetes

Indexed keywords

ANTIOXIDANT; CATALASE; GLUTATHIONE PEROXIDASE; MESSENGER RNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DENSITY; DIABETIC NEPHROPATHY; DISEASE COURSE; FEMALE; GENE EXPRESSION; GENETIC RISK; GENETIC VARIABILITY; GLOMERULAR STRUCTURE; GLOMERULUS BASEMENT MEMBRANE; GLOMERULUS FILTRATION RATE; HERITABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MESANGIUM CELL; MICROALBUMINURIA; PRIORITY JOURNAL; PROTEINURIA; SIBLING; SKIN FIBROBLAST; STATISTICAL SIGNIFICANCE; SURFACE PROPERTY;

ADULT; ANTIOXIDANTS; CATALASE; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; FEMALE; FIBROBLASTS; GLUTATHIONE PEROXIDASE; HUMANS; MALE; RNA, MESSENGER; SIBLINGS; SKIN;

EID: 33749998401     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl434     Document Type: Article

References (41)

1. Seaquist ER, Goetz FC, Rich S et al. Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 1989; 320: 1161-1165
2. Pettitt DJ, Saad MF, Bennett PH et al. Familial predisposition to renal disease in two generations of Pima Indians with type 2 (noninsulin-dependent) diabetes mellitus. Diabetologia 1990; 33: 438-443
3. Borch-Johnsen K, Norgaard K, Hommel E et al. Is diabetic nephropathy an inherited complication? Kidney Int 1992; 41: 719-722
4. Quinn M, Angelico MC, Warram JH et al. Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia 1996; 39: 940-945
5. Satko SG, Langefeld CD, Daeihagh P et al. Nephropathy in siblings of African Americans with overt type 2 diabetic nephropathy. Am J Kidney Dis 2002; 40: 489-494
6. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993; 329: 977-986
7. Krolewski AS, Warram JH, Rand LI et al. Epidemiologic approach to the etiology of type I diabetes mellitus and its complications. N Engl J Med 1987; 317: 1390-1398
8. Krolewski AS. Genetics of diabetic nephropathy: Evidence for major and minor gene effects. Kidney Int 1999; 55: 1582-1596
9. + antiport activity of cultured skin fibroblasts from diabetics. Kidney Int 1992; 42: 1184-1190
10. + antiporter. Kidney Int 1996; 50: 1684-1693
11. Huang C, Kim Y, Caramori ML et al. Cellular basis of diabetic nephropathy:. II. The transforming growth factor-beta system and diabetic nephropathy lesions in type 1 diabetes. Diabetes 2002; 51: 3577-3581
12. Trevisan R, Fioretto P, Barbosa J et al. Insulin-dependent diabetic sibling pairs are concordant for sodium-hydrogen antiport activity. Kidney Int 1999; 55: 2383-2389
13. Fioretto P, Steffes MW, Barbosa J et al. Is diabetic nephropathy inherited? Studies of glomerular structure in type 1 diabetic sibling pairs. Diabetes 1999; 48: 865-869
14. Maechler P, Jornot L, Wollheim CB. Hydrogen peroxide alters mitochondrial activation and insulin secretion in pancreatic beta cells. J Biol Chem 1999; 274: 27905-27913
15. Khamaisi M, Kavel O, Rosenstock M et al. Effect of inhibition of glutathione synthesis on insulin action: In vivo and in vitro studies using buthionine sulfoximine. Biochem J 2000; 349: 579-586
16. Evans JL, Goldfine ID, Maddux BA et al. Are oxidative stressactivated signaling pathways mediators of insulin resistance and beta-cell dysfunction? Diabetes 2003; 52: 1-8
17. Hoeldtke RD, Bryner KD, McNeill DR et al. Oxidative stress and insulin requirements in patients with recent-onset type 1 diabetes. J Clin Endocrinol Metab 2003; 88: 1624-1628
18. Matteucci E, Giampietro O. Oxidative stress in families of type 1 diabetic patients. Diabetes Care 2000; 23: 1182-1186
19. Zitouni K, Nourooz-Zadeh J, Harry D et al. Race-specific differences in antioxidant enzyme activity in patients with type 2 diabetes: A potential association with the risk of developing nephropathy. Diabetes Care 2005; 28: 1698-1703
20. Cowie CC, Port FK, Wolfe RA et al. Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes. N Engl J Med 1989; 321: 1074-1079
21. USRDS 2004 Annual Data Report. The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Bethesda, MD: 2004
22. Baynes JW, Thorpe SR. Role of oxidative stress in diabetic complications: A new perspective on an old paradigm. Diabetes 1999; 48: 1-9
23. Ceriello A, Morocutti A, Mercuri F et al. Defective intracellular antioxidant enzyme production in type 1 diabetic patients with nephropathy. Diabetes 2000; 49: 2170-2177
24. Chiarelli F, Di Marzio D, Santilli F et al. Effects of irbesartan on intracellular antioxidant enzyme expression and activity in adolescents and young adults with early diabetic angiopathy. Diabetes Care 2005; 28: 1690-1697
25. Hodgkinson AD, Bartlett T, Oates PJ et al. The response of antioxidant genes to hyperglycemia is abnormal in patients with type 1 diabetes and diabetic nephropathy. Diabetes 2003; 52: 846-851
26. Bhatia S, Shukla R, Venkata Madhu S et al. Antioxidant status, lipid peroxidation and nitric oxide end products in patients of type 2 diabetes mellitus with nephropathy. Clin Biochem 2003; 36: 557-562
27. + antiport activity in cultured fibroblasts from NIDDM patients with hypertension and microalbuminuria. Diabetologia 1996; 39: 717-724
28. Caramori ML, Kim Y, Huang C et al. Cellular basis of diabetic nephropathy. 1. Study design and renal structural-functional relationships in patients with long-standing type 1 diabetes. Diabetes 2002; 51: 506-513
29. Bakris GL, Williams M, Dworkin L et al. Preserving renal function in adults with hypertension and diabetes: A consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Am J Kidney Dis 2000; 36: 646-661
30. Chobanian AV, Bakris GL, Black HR et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 2003; 289: 2560-2572
31. Chavers BM, Simonson J, Michael AF. A solid phase fluorescent immunoassay for the measurement of human urinary albumin. Kidney Int 1984; 25: 576-578
32. Ellis EN, Steffes MW, Goetz FC et al. Glomerular filtration surface in type I diabetes mellitus. Kidney Int 1986; 29: 889-894
33. Jensen EB, Gundersen HJ, Osterby R. Determination of membrane thickness distribution from orthogonal intercepts. J Microsc 1979; 115: 19-33
34. Fioretto P, Steffes MW, Mauer M. Glomerular structure in nonproteinuric IDDM patients with various levels of albuminuria. Diabetes 1994; 43: 1358-1364
35. Steffes MW, Bilous RW, Sutherland DE et al. Cell and matrix components of the glomerular mesangium in type I diabetes. Diabetes 1992; 41: 679-684
36. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159
37. Almasy L, Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 1998; 62: 1198-1211
38. Nishikawa T, Edelstein D, Brownlee M. The missing link: A single unifying mechanism for diabetic complications. Kidney Int 2000; 58 [Suppl 77]: S26-30
39. Brownlee M. The pathobiology of diabetic complications: A unifying mechanism. Diabetes 2005; 54: 1615-1625
40. Matteucci E, Giampietro O. Oxidative stress in families of type 1 diabetic patients - further evidence. Diabetes Care 2001; 24: 167-168
41. + exchange in neonatal rat cardiac myocytes. Circ Res 1998; 82: 1053-1062